Recently, the A-share market has seen a surge of companies planning to list in Hong Kong, with several well-known enterprises officially announcing their intentions to be listed on the Main Board of the Hong Kong Stock Exchange, including Jiangbolong, Maiwei Biotech, Zhejiang Sanhua Intelligent Controls, Foshan Haitian Flavouring and Food, and Jiangsu Hengrui Pharmaceuticals. In fact, this year, boosted by the successful listings of Midea Group Co., Ltd and S.F. Holding in the Hong Kong market, the IPO market for new stocks in Hong Kong is also showing signs of vigorous growth. In Hong Kong, efforts are actively underway to shorten the IPO approval process and create a fast track for A-shares with a market cap of 10 billion to list in Hong Kong. On December 19, the Hong Kong Stock Exchange published a consultation document advising on reducing the minimum threshold for H-shares for companies planning to go public in Hong Kong using the A+H share model. Ouyang Zhenxing, the managing partner for Deloitte South China, believes that it is mainly due to the support from the mainland for leading companies to list in Hong Kong. With the acceleration of the approval process for overseas listings, it is anticipated that there will be more "A first, then H" listings next year, which will be a key driving force for the prosperity of the IPO market in Hong Kong. (Securities Times)